Navigation Links
Hologic Announces Fourth Quarter and Fiscal 2012 Operating Results
Date:11/12/2012

ly. 

HOLOGIC, INC.RECONCILIATION OF GAAP REVENUES, EPS AND NET (LOSS) INCOME TO NON-GAAP ADJUSTED REVENUES, EPS, NET INCOME AND EBITDA(Unaudited)(In thousands, except earnings per share)Year EndedSeptember 29, 2012September 24, 2011REVENUESGAAP revenues

$
2,002,652Adjustment related to Novartis collaboration

11,606Non-GAAP adjusted revenues

$
2,014,258

(1)(LOSS) EARNINGS PER SHAREGAAP (loss) earnings per share- Diluted

$
(0.28)$
.59Adjustments to net (loss) income (as detailed below)

1.660.68Non-GAAP adjusted earnings per share- Diluted

$
.38

(2)$
.27

(2)NET (LOSS) INCOMEGAAP net (loss) income 

$
(73,634)$
57,150Adjustments:Contingent revenue from Novartis collaboration

11,606-Amortization of intangible assets273,900235,790Contingent consideration 

119,49711,986Non-cash interest expense relating to convertible notes

68,53272,908Acquisition-related costs

45,6332,316Non-cash loss on convertible notes exchange

42,34729,891Restructuring and divestiture

17,036(71)Fair value write up of acquired inventory sold

19,9183,298Adiana closure costs

19,543-Impairment of goodwill

5,826-In-process research and development

4,500-Fair value adjustment for depreciation expense

2,503-Gain on sale of intellectual property, net

(12,424)(84,502)Other charges

4523,215Income tax effect of reconciling items

(177,478)

(3)(96,500)

(3)Non-GAAP adjusted net income

$
367,757$
335,481EBITDANon-GAAP adjusted net income

$
367,757$
335,481Interest expense, net, not adjusted above

68,88739,864Provision for income taxes

189,451166,736Depreciation expense, not adjusted above69,34868,946Adjusted EBITDA

$
95,443$
,027EXPLANATORY NOTES:(1) To reflect a fair value adj
'/>"/>

SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine technology :

1. Hologic to Showcase Advancement Simplifying Removal of Large Intrauterine Pathology at AAGL
2. Hologic, Inc. Marks Breast Cancer Awareness Month by Ringing the Opening Bell at NASDAQ and Taking 3D Mammography on the Road
3. Hologic Announces Verdict In Patent Infringement Suit
4. Hologic To Participate In The Morgan Stanley Global Healthcare Conference
5. Senator Blumenthal, a Strong Advocate for Womens Health, Visits Hologics Manufacturing Facility in Danbury, CT
6. Hologic Completes Acquisition Of Gen-Probe
7. Hologic Announces Third Quarter Fiscal 2012 Operating Results
8. Hologic Announces Pricing Of Financing In Connection With Acquisition Of Gen-Probe
9. Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme
10. Hologic and Gen-Probe Announce Clearance from German Federal Cartel Office for Hologics Acquisition of Gen-Probe
11. Hologic And Gen-Probe Provide Update On Pending Transaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... by Equipment Type (Benchtop, Mobile, Industrial, & Laboratory), ... Technology (Tray-style, Manifold, & Rotary) & Geography - ... MarketsandMarkets, defines and segments the lyophilization market on ... with analyses and projections of the market size ...
(Date:9/19/2014)... -- BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a biopharmaceutical ... ® in the U.S. and XIAPEX ® in ... , will present a corporate overview at the 21 st ... The presentation will take place on Friday, September ... Hotel in New York, NY . A ...
(Date:9/19/2014)... , Sept. 19, 2014 Intarcia ... interim clinical data for its lead candidate ITCA 650 ... patients with high baseline HbA1c levels at the 50 ... the Study of Diabetes (EASD). Data from the open-label, ... levels of blood sugar in patients with poorly controlled ...
Breaking Medicine Technology:Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... (NYSE: HRC ) invites you to listen to ... Conference in New York City on February 15, 2012, at ... to the live discussion via the internet link at  http://ir.hill-rom.com/events.cfm ... recorded replay of the discussion will be available one hour ...
... growing stronger and stronger for one of the most ... on February 21-22, 2012 at the Renaissance Zurich Hotel ... 150 top pharmaceutical executives already attending, people are already ... among the industry,s influential decision makers," says conference organizer ...
Cached Medicine Technology:World's Leading Pharmaceutical Executives All Converging in Zurich, Switzerland on February 21-22, 2012 for Breakthrough Event 2
(Date:9/21/2014)... public health authorities focus on the physical activity benefits ... of Montreal reveals that for children, playing has no ... activity that is fun, done alone or with friends, ... pleasure, but also to combat boredom, sadness, fear, or ... play, authorities put aside several aspects of play that ...
(Date:9/21/2014)... PhUSE is proud to announce Dr. Pritpal Tamber, ... speakers for their 10th annual conference which is themed ... in 2013 , Charles Sabine in 2012 ... again presents high-calibre speakers to talk about relevant topics ... information. , Dr. Pritpal Tamber is a "health explorer" ...
(Date:9/21/2014)... 2014 Burnaby Physiotherapists at Absolute PhysioCare ... in order to help them with preventative care. This ... clinic that will help clients understand their problem in ... active participation in the healing process. With higher knowledge ... be able to facilitate the therapy that is initiated ...
(Date:9/21/2014)... York, NY (PRWEB) September 21, 2014 ... that help businesses and manufacturers perform tests on items ... In an increasingly regulated society, pressure on operators to ... higher than ever. A greater number of government safety ... of manufacturers' goods prior to sale. Although revenue briefly ...
(Date:9/21/2014)... September 21, 2014 Over the past ... drugs to inundate the market, thereby cutting into revenue ... industry. According to data from Industry Canada, the loss ... industry $1.8 and $2.5 billion in 2010 and 2012, ... patent exclusivity, which has hampered revenue growth, many pharmaceutical ...
Breaking Medicine News(10 mins):Health News:Narrow focus on physical activity could be ruining kids' playtime 2Health News:PhUSE announces Final List of Industry Influencers as Keynote Speakers 2Health News:PhUSE announces Final List of Industry Influencers as Keynote Speakers 3Health News:Burnaby Physiotherapists Now Provide Educational Information for Preventative Care 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 3
... A new season of Dancing With The Stars begins with new cast members and a new diet firmly in ... Nicole Scherzinger , Kate Gosselin , Shannen Doherty , new Olympic champion, Evan Lysacek , ... Jake Pavelka . , ... ...
... March 22 CCH has issued a Special Tax ... reform legislation. With the passage of the Patient Protection and ... Education Tax Credits Reconciliation Act in the House, the stage ... signing by the president to wind up the long legislative path ...
... founder of healthcare IT company, Ingenious Med, is among the more than 150 hospitalists nationwide who have earned the inaugural designation of Senior Fellow in Hospital Medicine (SFHM). , ... , ... ... ...
... psychiatric drugs. , ... , , ... ... The research was conducted by Thomson Reuters, ...
... supernatural forces are common in Ghana and other African ... witchcraft. Over thirty per cent of its inhabitants believe ... of HIV/AIDS. When meeting Ghanian colleagues, professor and ... confronted with intellectually challenging issues. "The spread ...
... Everett and Walid Saleh, a scholar of religion ... selected to receive a highly competitive New Directions Fellowship ... It is the first time the fellowships, created in ... The New Directions Fellowships are unique in ...
Cached Medicine News:Health News:The Fresh Diet Dances With The Stars Keeping the Cast in Shape and on Its Toes 2Health News:The Fresh Diet Dances With The Stars Keeping the Cast in Shape and on Its Toes 3Health News:CCH Issues Briefing on Tax Provisions of Health Care Reform Legislation 2Health News:CCH Issues Briefing on Tax Provisions of Health Care Reform Legislation 3Health News:CCH Issues Briefing on Tax Provisions of Health Care Reform Legislation 4Health News:Ingenious Med Founder, Steven Liu, Earns Senior Fellow in Hospital Medicine Designation 2Health News:Ingenious Med Founder, Steven Liu, Earns Senior Fellow in Hospital Medicine Designation 3Health News:Ingenious Med Founder, Steven Liu, Earns Senior Fellow in Hospital Medicine Designation 4Health News:Thomson Reuters Study Offers New Insight on How Physicians Prescribe Psychiatric Drugs 2Health News:Thomson Reuters Study Offers New Insight on How Physicians Prescribe Psychiatric Drugs 3Health News:Thomson Reuters Study Offers New Insight on How Physicians Prescribe Psychiatric Drugs 4Health News:Thomson Reuters Study Offers New Insight on How Physicians Prescribe Psychiatric Drugs 5Health News:Modern medicine conquers witchcraft 2Health News:Modern medicine conquers witchcraft 3Health News:Modern medicine conquers witchcraft 4Health News:University of Toronto scholars receive prestigious New Directions Fellowships 2
Albumin FS for determination of albumin in serum or plasma. For Hitachi 704 / 911. Available with Calibrator: Trucal U and Controls: Trulab N and Trulab P....
Intended for the quantitative determination of albumin in serum or plasma. Reaction: Endpoint. Wavelength: 628 nm. Linearity: 8 g/dl (80 g/l). Ready to use liquid reagent....
AST (SGOT) reagent is used for the quantitative determination of aspartate aminotransferase (AST) in human serum....
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 268 U/L at 30C. Two vials, dry powder reagents...
Medicine Products: